Duruisseaux, M., Besse, B., Girard, N., Dansin, E., Cousin, S., Mazières, J., Doucet, L., Madroszyk, A., Greillier, L., Ricordel, C., Cavaillon, S., Mascaux, C., Vicier, C., Tosi, D., Calattini, S., Schwiertz, V., Bin, S., Subtil, F., You, B., Pierret, T. (2025). IMMUNORARE
            <sup>5</sup>
            : A national platform of 5 academic phase II trials coordinated by Lyon University Hospital to assess the safety and the efficacy of the immunotherapy with domvanalimab + zimberelimab combination in patients with advanced rare cancers—The B3 Thymomas and Thymic Carcinomas Cohort.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps8130